The Effect of Cardiovascular Medications on Disease-Related Outcomes in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
Background: Multiple studies have revealed that idiopathic pulmonary fibrosis (IPF) patients are more at risk for cardiovascular diseases and that many IPF patients receive cardiovascular medications like statins, angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB), an...
Saved in:
Main Authors: | Wan-Tong Zhang (Author), Xu-Jie Wang (Author), Chun-Miao Xue (Author), Xin-Yu Ji (Author), Lin Pan (Author), Wei-Liang Weng (Author), Qiu-Yan Li (Author), Guo-Dong Hua (Author), Bao-Chen Zhu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Dong Weng, et al.
Published: (2019) -
Inhibition of Aspirin-Induced Gastrointestinal Injury: Systematic Review and Network Meta-Analysis
by: Wan-tong Zhang, et al.
Published: (2021) -
In the Spirit of Benevolence: Taking Action to Fight Against the COVID-19 Pandemic
by: Xu-Jie Wang, et al.
Published: (2022) -
Plasma Leptin Is Elevated in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Mengshu Cao, et al.
Published: (2016) -
Idiopathic Pulmonary Fibrosis
Published: (2022)